MARKET

ERNA

ERNA

Ernexa
NASDAQ
4.530
+0.320
+7.60%
Pre Market: 4.520 -0.01 -0.22% 05:19 08/11 EDT
OPEN
4.240
PREV CLOSE
4.210
HIGH
4.748
LOW
4.210
VOLUME
70
TURNOVER
23.11K
52 WEEK HIGH
71.50
52 WEEK LOW
3.183
MARKET CAP
7.39M
P/E (TTM)
-0.1486
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
Dow Jones · 22h ago
Weekly Report: what happened at ERNA last week (0803-0807)?
Weekly Report · 1d ago
Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
Barchart · 1d ago
Weekly Report: what happened at ERNA last week (0727-0731)?
Weekly Report · 08/03 10:15
Weekly Report: what happened at ERNA last week (0720-0724)?
Weekly Report · 07/27 10:19
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
Barchart · 07/24 08:20
Weekly Report: what happened at ERNA last week (0713-0717)?
Weekly Report · 07/20 10:16
3 Most Active Penny Stocks to Watch Today, 7/16/2026
TipRanks · 07/16 14:52
More
About ERNA
Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The Company is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The Company seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The Company is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.

Webull offers Ernexa Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.